HomeIMUX • NASDAQ
add
Immunic Inc
Previous close
$0.69
Day range
$0.66 - $0.69
Year range
$0.56 - $1.39
Market cap
79.74M USD
Avg Volume
1.24M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 25.99M | 1.04% |
Net income | -25.58M | -4.97% |
Net profit margin | — | — |
Earnings per share | -0.13 | 45.83% |
EBITDA | -25.95M | -1.05% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 35.13M | -40.53% |
Total assets | 40.70M | -37.15% |
Total liabilities | 30.20M | 28.30% |
Total equity | 10.50M | — |
Shares outstanding | 120.28M | — |
Price to book | 6.26 | — |
Return on assets | -127.25% | — |
Return on capital | -281.43% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -25.58M | -4.97% |
Cash from operations | -20.14M | 3.15% |
Cash from investing | -67.00K | -34.00% |
Cash from financing | 0.00 | — |
Net change in cash | -20.18M | 2.18% |
Free cash flow | -9.39M | 24.31% |
About
CEO
Founded
May 2003
Website
Employees
90
